Inflammatory cytokine signaling contributes to Erlotinib resistance in head and neck squamous cell carcinoma
Resistance to epidermal growth factor receptor tyrosine kinase inhibitors (EGFR TKIs) is a major obstacle in the success of head and neck cancer therapy. Despite efforts by several groups to understand the mechanisms of resistance to tyrosine kinase inhibitors such as erlotinib, there has been littl...
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | English |
| Published: |
University of Iowa
2016
|
| Subjects: | |
| Online Access: | https://ir.uiowa.edu/etd/3194 https://ir.uiowa.edu/cgi/viewcontent.cgi?article=6524&context=etd |